impf-info.de

Nachdem Covid19 aus medizinischer Sicht "durch" ist, hier jetzt also wieder das Thema Impfen in ganzer Breite...
Font size: +

FDA zu Novavax: Wirksamkeit gegen Omikron "more likely than not" - 4 Fälle von Myokarditis in US-amerikanischer Zulassungsstudie...

...

U.S. FDA staff says Novavax vaccine lowers COVID risk | Reuters

U.S. Food and Drug Administration staff said on Friday Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and that it was likely the shot could provide some level of protection against the Omicron variant.
Nesselsucht nach Covid-Impfung - ein Klassiker für...
Lancet-Studie zur booster-Wirksamkeit unter Omikro...

By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/